The acceptability mass administrations of anti-malarial drug as part of targeted malaria elimination in villages along the Thai-Myanmar border

Malaria Journal

Volumn 15, Issue 1, 2016, Pages

  Kajeechiwa, Ladda ^a   Thwin, May Myo ^a   Shee, Paw Wah ^a   Yee, Nan Lin ^a   Elvina, Elvina ^a   Peapah, Peapah ^a   Kyawt, Kyawt ^a   Oo, Poe Thit ^a   Powah, William ^a   Min, Jacqueline Roger ^a   Wiladphaingern, Jacher ^a   Von Seidlein, Lorenz ^b   Nosten, Suphak ^a   Nosten, Francois ^a,c  

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acceptance; Behaviour; Community engagement; Knowledge; Malaria; Mass drug administration; Social mobilisation; Targeted malaria control

Indexed keywords

ANTIMALARIAL AGENT; DIHYDROARTEMISININ PLUS PIPERAQUINE; PRIMAQUINE; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; PIPERAQUINE; QUINOLINE DERIVATIVE;

ADULT; ARTICLE; COMMUNITY; CONTROLLED STUDY; DISEASE ELIMINATION; DRUG ADMINISTRATION; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALARIA; MALE; MASS DRUG ADMINISTRATION; MYANMAR; PATIENT PARTICIPATION; PROGRAM ACCEPTABILITY; RURAL AREA; THAILAND; ADOLESCENT; AGED; ANIMAL; CHILD; DISEASE ERADICATION; DISEASE TRANSMISSION; INFANT; MIDDLE AGED; PATIENT ATTITUDE; PREGNANCY; PRESCHOOL CHILD; PREVENTION AND CONTROL; PROCEDURES; QUESTIONNAIRE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DISEASE ERADICATION; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HUMANS; INFANT; MALARIA; MALE; MIDDLE AGED; MYANMAR; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PRIMAQUINE; QUINOLINES; SURVEYS AND QUESTIONNAIRES; THAILAND; YOUNG ADULT;

EID: 84988704575     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1528-7     Document Type: Article

References (18)

1. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411-23.
2. Imwong M, Hanchana S, Malleret B, Renia L, Day NP, Dondorp A, et al. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol. 2014;52:3303-9.
3. Newby G, Hwang J, Koita K, Greenwood B, von Seidlein L, Shanks D, et al. Review of mass drug administration and primaquine use for malaria. Am J Trop Med Hyg. 2015;93:125-34.
4. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for malaria. Cochrane Database Syst Rev. 2013;12:CD008846.
5. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Bjorkman A. Malaria eradication on islands. Lancet. 2000;356:1560-4.
6. Atkinson JA, Vallely A, Fitzgerald L, Whittaker M, Tanner M. The architecture and effect of participation: a systematic review of community participation for communicable disease control and elimination. Implications for malaria elimination. Malar J. 2011;10:225.
7. Zani B, Gathu M, Donegan S, Olliaro PL, Sinclair D. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst Rev. 2014;1:CD010927.
8. Watanabe N, Kaneko A, Yamar S, Taleo G, Tanihata T, Lum JK, et al. A prescription for sustaining community engagement in malaria elimination on Aneityum Island, Vanuatu: an application of Health Empowerment Theory. Malar J. 2015;14:291.
9. Kaneko A. A community-directed strategy for sustainable malaria elimination on islands: short-term MDA integrated with ITNs and robust surveillance. Acta Trop. 2010;114:177-83.
10. De Martin S, von Seidlein L, Deen JL, Pinder M, Walraven G, Greenwood B. Community perceptions of a mass administration of an antimalarial drug combination in The Gambia. Trop Med Int Health. 2001;6:442-8.
11. Dial NJ, Ceesay SJ, Gosling RD, D'Alessandro U, Baltzell KA. A qualitative study to assess community barriers to malaria mass drug administration trials in The Gambia. Malar J. 2014;13:47.
12. Dierickx S, Gryseels C, Mwesigwa J, O'Neill S, Bannister-Tyrell M, Ronse M, et al. Factors associated with non-participation and non-adherence in directly observed mass drug administration for malaria in The Gambia. PLoS One. 2016;11:e0148627.
13. Imwong M, Nguyen TN, Tripura R, Peto TJ, Lee SJ, Lwin KM, et al. The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam. Malar J. 2015;14:381.
14. Njomo DW, Mukoko DA, Nyamongo NK, Karanja J. Increasing coverage in mass drug administration for lymphatic filariasis elimination in an urban setting: a study of Malindi Town, Kenya. PLoS One. 2014;9:e83413.
15. Geissler PW, Kelly A, Imoukhuede B, Pool R. 'He is now like a brother, I can even give him some blood' - relational ethics and material exchanges in a malaria vaccine 'trial community' in The Gambia. Soc Sci Med. 2008;67:696-707.
16. Geissler PW, Pool R. Popular concerns about medical research projects in sub-Saharan Africa - a critical voice in debates about medical research ethics. Trop Med Int Health. 2006;11:975-82.
17. Gilson L. Trust and the development of health care as a social institution. Soc Sci Med. 2003;56:1453-68.
18. Molyneux CS, Peshu N, Marsh K. Trust and informed consent: insights from community members on the Kenyan coast. Soc Sci Med. 2005;61:1463-73.